{"organizations": [], "uuid": "0aaac5a9581d6022779ba2926833976ab0e30da6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180212.html", "section_title": "Archive News &amp; Video for Monday, 12 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-carl-zeiss-meditec-sees-fy-adj-ebi/brief-carl-zeiss-meditec-sees-fy-adj-ebit-margin-at-14-16-pct-idUSASM000J6E", "country": "US", "domain_rank": 408, "title": "BRIEF-Carl Zeiss Meditec Sees FY Adj EBIT Margin At 14-16 Pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-12T14:01:00.000+02:00", "replies_count": 0, "uuid": "0aaac5a9581d6022779ba2926833976ab0e30da6"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-carl-zeiss-meditec-sees-fy-adj-ebi/brief-carl-zeiss-meditec-sees-fy-adj-ebit-margin-at-14-16-pct-idUSASM000J6E", "ord_in_thread": 0, "title": "BRIEF-Carl Zeiss Meditec Sees FY Adj EBIT Margin At 14-16 Pct", "locations": [], "entities": {"persons": [{"name": "carl zeiss", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "meditec ag", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 12 (Reuters) - Carl Zeiss Meditec AG:\n* DGAP-NEWS: CARL ZEISS MEDITEC AG STARTS NEW FISCAL YEAR 2017/18 WITH SOLID REVENUE GROWTH\n* Q1 ‍REVENUE INCREASED BY 5.3 PERCENT​ * Q1 ‍REVENUE 294.7 MILLION EUROS * ‍Q1 EBIT 38.9 MILLION EUROS * Q1 ‍ADJUSTED EBIT MARGIN 13.5 PERCENT * ‍OBJECTIVE FOR FISCAL YEAR 2017/18 CONTINUES TO BE TO GROW AT AT LEAST SAME RATE AS UNDERLYING MARKET​\n* ‍EBIT MARGIN IS EXPECTED TO BE WITHIN RANGE ALSO FORECAST FOR MEDIUM TERM, OF 14 TO 16 PERCENT ON AN ADJUSTED BASIS​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-12T14:01:00.000+02:00", "crawled": "2018-02-13T15:57:46.001+02:00", "highlightTitle": ""}